CHICAGO – May 20, 2021 – First Analysis acted as the exclusive financial advisor to SymphonyRM for its $25 million Series B funding. SymphonyRM transforms healthcare providers into member-focused enterprises through its innovative HealthOS platform. The round was led by new investment partner TT Capital Partners with continued investment from Adams Street Partners.
The capital injection will further fuel SymphonyRM’s sales and marketing efforts to support the accelerated demand for actionable intelligence that helps provider and payer organizations maximize patient outcomes and revenue growth. SymphonyRM also plans to increase its reach and footprint in the payer segment by leveraging data science and sophisticated artificial intelligence (AI) to create next best actions that improve member experiences.
“AI is promising the opportunity to transform the U.S. healthcare system,” said First Analysis Managing Director Andrew Walsh. “SymphonyRM is a great example of this, with its approach to data-driven next best actions as a means for healthcare systems, provider organizations and payers to better engage patients along their healthcare journey. With this successful round of growth capital, I look forward to watching SymphonyRM’s continued innovation around patient engagement.”
“We found a great partner in First Analysis – the team understood our growth objectives and unique positioning. The team’s deep industry expertise and ability to guide us through the process led to a fantastic outcome,” said Michael Linnert, CEO of SymphonyRM. “First Analysis has helped build a fantastic team to support us in this new chapter of growth.”
First Analysis focuses its advisory services on high-growth, entrepreneur-driven companies like SymphonyRM. The First Analysis team worked closely with the management team to optimally position the company and find the best partner to help SymphonyRM to continue to achieve its growth objectives. First Analysis was actively engaged throughout the transaction process, including preparation, positioning, investor coordination and contact, due diligence and negotiation.
SymphonyRM is helping health systems transform how they acquire, engage, and retain patients by creating an engagement model rivaling the capabilities of world-class, consumer-centered organizations. By generating data-driven, prioritized next best actions for every consumer, prospect and provider in a health system, SymphonyRM is helping organizations anticipate member needs and use proactive outreach to build deeper customer relationships and drive better outcomes while increasing revenue.
About First Analysis
Founded in 1981, First Analysis has a 40-year track record of serving emerging growth companies and established industry leaders within its focused areas of domain expertise. Our investment banking practice leverages industry insights developed through our research and investing activities to deliver value to clients across the life cycle of a business. Providing senior-level attention to every client, First Analysis offers superior execution across a comprehensive range of investment banking services, including M&A advisory and growth financings.
To download a pdf version of this press release, please follow the link below:
First Analysis acted as the exclusive financial advisor to SymphonyRM for its $25 million Series B funding led by TT Capital Partners
First Analysis Securities Corp. (FASC) is a registered broker/dealer with FINRA and member SIPC.